Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications

Despite intense efforts there is no safe and efficacious vaccine against visceral leishmaniasis, which is fatal and endemic in many tropical countries. A major shortcoming in the vaccine development against blood-borne parasitic agents such as Leishmania is the inadequate predictive power of the ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Gannavaram, Sreenivas, Dey, Ranadhir, Avishek, Kumar, Selvapandiyan, Angamuthu, Salotra, Poonam, Nakhasi, Hira L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033241/
https://www.ncbi.nlm.nih.gov/pubmed/24904589
http://dx.doi.org/10.3389/fimmu.2014.00241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033241/
https://www.ncbi.nlm.nih.gov/pubmed/24904589
http://dx.doi.org/10.3389/fimmu.2014.00241

Ejemplares similares